The apparent benefits at 2 years observed in the nonrandomized ALT-FLOW study pave the way for a sham-controlled trial.

Congestive heart failure (CHF) and heart failure are the same thing. Both terms describe the inability of the heart to pump enough blood to service the body's needs. The term "congestive" simply ...

Bayer seeks Japanese marketing approval for finerenone to treat adult patients with chronic heart failure: Berlin Saturday, February 15, 2025, 14:00 Hrs [IST] Bayer announced the ...

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), a pharmaceutical company with a market capitalization of $72.6 million, has ...

These early data are reassuring, but there are many questions yet to be explored in the upcoming pivotal trial, Nancy ...

A groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets for heart failure (HF) and its ...

A novel transcatheter-implanted system that shunts blood flow from the left to right atrium through the coronary sinus has ...

Slower gait speed, but not handgrip strength or muscle mass, is associated with an increased risk for cardiovascular outcomes ...

Background The Prognostic Nutritional Index (PNI), calculated from serum albumin levels and lymphocyte counts, is a simple ...

Background Iron deficiency (ID) is common in patients with atrial fibrillation/flutter (AF), but its prognostic implications and optimal diagnostic criteria, particularly in those with and without ...

There is an unmet need for therapies targeting Duchenne muscular dystrophy (DMD)–related heart disease, and phase 2 results ...